Legumain/pH dual-responsive lytic peptide–paclitaxel conjugate for synergistic cancer therapy

Authors: Shanshan Zheng, Yue Cai, Yulu Hong, Yubei Gong, Licheng Gao, Qingyong Li, Le Li, Xuanrong Sun

https://doi.org/10.1080/10717544.2022.2081380, 2022

Published in: Drug Delivery

Tags: Peptide–drug conjugate; legumain-responsive; pH-responsive; synergistic cancer therapy